J. Baxter

发表

The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine.

R. Clark, M. Samnaliev, J. Baxter, 2011, Health affairs.

Utilizing a Faculty Development Program to Promote Safer Opioid Prescribing for Chronic Pain in Internal Medicine Resident Practices

M. Winter, A. Jackson, D. Alford, 2019, Pain medicine.

The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence.

B. Barton, W. Fisher, R. Clark, 2014, Health services research.

Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?

R. Clark, J. Baxter, 2013, JAMA internal medicine.

Minimizing the Misuse of Prescription Opioids in Patients with Chronic Non-Malignant Pain

J. Baxter, 2012 .

Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.

B. Barton, W. Fisher, R. Clark, 2015, Journal of substance abuse treatment.

Patterns of Health Care Utilization for Asthma Treatment in Adults with Substance Use Disorders

R. Clark, M. Samnaliev, J. Baxter, 2008, Journal of addiction medicine.

Substance Abuse and Depression

D. Ciraulo, J. Baxter, J. Renner, 1994 .

The Quality of Asthma Care Among Adults With Substance-Related Disorders and Adults With Mental Illness

R. Clark, M. Samnaliev, J. Baxter, 2009 .

Predictors of prenatal and postpartum care adequacy in a medicaid managed care population.

R. Clark, J. Baxter, S. Weir, 2011, Women's health issues : official publication of the Jacobs Institute of Women's Health.

Factors associated with Medicaid patients' access to buprenorphine treatment.

R. Clark, M. Samnaliev, J. Baxter, 2011, Journal of substance abuse treatment.

Co-occurring risk factors for arrest among persons with opioid abuse and dependence: implications for developing interventions to limit criminal justice involvement.

Bruce Barton, William H Fisher, B. Barton, 2014, Journal of substance abuse treatment.

Disparities in routine breast cancer screening for Medicaid managed care members with a work-limiting disability.

R. Clark, J. Baxter, S. Weir, 2011, Medicare & medicaid research review.

Adherence to Buprenorphine Treatment Guidelines in a Medicaid Program

R. Clark, M. Samnaliev, J. Baxter, 2015, Substance abuse.

Pre-competition anxiety contagion among collegiate male volleyball players

J. Baxter, 2014 .

The Surgeon General's Facing Addiction Report: An Historic Document for Health Care

K. Kraemer, D. Alford, J. Seale, 2017, Substance abuse.

Beyond Health Plans: Behavioral Health Disorders and Quality of Diabetes and Asthma Care for Medicaid Beneficiaries

R. Ouellette, R. Clark, J. Baxter, 2009, Medical care.

The quality of asthma care among adults with substance-related disorders and adults with mental illness.

R. Clark, M. Samnaliev, J. Baxter, 2009, Psychiatric services.

Patterns of Health Care Utilization for Asthma Treatment in Adults with Substance Use Disorders

R. Clark, M. Samnaliev, J. Baxter, 2008, Journal of addiction medicine.

Regular article Factors associated with Medicaid patients' access to buprenorphine treatment

J. Baxter, Robin E. Clark, Mihail D. Samnaliev, 2011 .

The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine.

R. Clark, M. Samnaliev, J. Baxter, 2011, Health affairs.

Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.

B. Barton, W. Fisher, R. Clark, 2015, Journal of substance abuse treatment.

Comparative evaluation of two asthma care quality measures among Medicaid beneficiaries.

R. Clark, M. Samnaliev, J. Baxter, 2009, Chest.